Valink Therapeutics

Valink Therapeutics is dedicated to pioneering the next generation of antibody-based therapeutics. Their innovative approach involves identifying novel mechanisms of action from well-established targets. This is achieved by simultaneously incorporating multiple antibody modifications, enabling the rapid and scalable generation of complex drug candidates. These candidates feature bi- or multi-specificity, multivalency, and drug-conjugation within a single, streamlined discovery process. Valink's primary research focus is on developing effective treatments for solid tumors that have shown poor responses to existing immunotherapy approaches.